Multifocal acquired sensory and motor neuropathy: Electrodiagnostic features

Journal of Clinical Neuromuscular Disease

Volumn 7, Issue 1, 2005, Pages 10-18

  Magda, Paul ^a   Latov, Norman ^a   Brannagan III, Thomas H ^a   Goldfarb, Adina ^a   Chin, Russell L ^a   Sander, Howard W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; CIDP; Electrodiagnostic criteria; Multifocal CIDP; Multifocal sensory and motor neuropathy

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; DEMYELINATION; DISEASE DURATION; ELECTRODIAGNOSIS; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; PATIENT SELECTION; PRIORITY JOURNAL; SENSORY NEUROPATHY;

EID: 24344437277     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cnd.0000176973.53512.e4     Document Type: Article

References (28)

1. Mendell JR, Kissel JT, Cornblath DR. Evaluation of the patient with peripheral neuropathy: the challenges. In: Mendell JR, Kissel JT, Cornblath DR, eds. Diagnosis and Management of Peripheral Nerve Disorders. New York: Oxford University Press; 2001:3-9.
2. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32:958-964.
3. Saperstein DS, Katz JS, Amato AA, et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001;24:311-324.
4. Alaedini A, Sander HW, Hays AP, et al. Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy. Arch Neurol. 2003;60:42-46.
5. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991;41:617-618.
6. Magda P, Latov N, Brannagan TH III, et al. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol. 2003; 60:1755-1759.
7. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myoinosital related to sural nerve morphometry. Ann Neurol. 1980;8:590-596.
8. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195-201.
9. Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2002;25:26-30.
10. Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology. 2002;59:1526-1532.
11. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology. 2003;60(Suppl 3): S8-S15.
12. Kimura J. The F wave and the A wave. In: Kimura J, ed. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice, 3rd ed. New York: Oxford University Press; 2001:449-460.
13. Rhee EK, England JD, Sumner AJ. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol. 1990;28:146-156.
14. Fraser JL, Olney RK. The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies. Muscle Nerve. 1992;15:912-918.
15. Alaedini A, Sander HW, Hays AP, et al. Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy. Arch Neurol. 2003;60:42-46.
16. Chroni E, Hall SM, Hughes RA. Chronic axonal neuropathy: a first case report. Ann Neurol. 1995; 37:112-115.
17. Morino S, Antonini G. Another case of chronic relapsing axonal neuropathy. Muscle Nerve. 1996; 19:533-534.
18. Notermans NC, Wokke JHJ. Chronic idiopathic axonal polyneuropathy. Muscle Nerve. 1996;19: 1637-1638.
19. Uncini A, Sabatelli M, Mignogna T, et al. Chronic progressive steroid responsive axonal polyneuropathy: a CIDP variant or a primary axonal disorder. Muscle Nerve. 1996;19:365-371.
20. Van den Bergh PYK. Chronic relapsing axonal neuropathy responsive to intravenous immunoglobulin. Neurology. 1998;50:1514.
21. Ellis CM, Leary S, Payan J, et al. Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry. 1999; 67:15-19.
22. Gorson KC, Ropper AH, Weinberg DH, et al. Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy. Arch Neurol. 2002;59:766-772.
23. Katz JS, Barohn RJ, Kojan S, et al. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology. 2002; 58:615-620.
24. Vallat JM, Tabaraud F, Magy L, et al. Chronic polyradiculoneuritis and its frontiers. Rev Neurol. 2002;158:S27-S31.
25. Vallat JM, Tabaraud F, Magy L, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve. 2003;27:478-485.
26. Gong Y, Tagawa Y, Lunn MPT, et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain. 2002;125:2491-2506.
27. Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve. 1999;22:560-566.
28. Viala K, Renie L, Maisonobe T, et al. Follow up study and response to treatment in 23 patients with Lewis Sumner syndrome. Brain. 2004;127:2010-2017.